{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:34:17Z","timestamp":1768829657967,"version":"3.49.0"},"reference-count":60,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science and Technology","award":["109-2813-C-005-036-B"],"award-info":[{"award-number":["109-2813-C-005-036-B"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>We have recently developed probiotics that can express bovine, human, or porcine lactoferrin (LF), and the present study evaluated the effect of these probiotics in improving non-alcoholic fatty liver disease (NAFLD). Three kinds of probiotic supplements, including lactic acid bacteria (LAB), LAB\/LF, and inactivated LAB\/LF, were prepared. The LAB supplement was prepared from 10 viable LAB without recombinant LF-expression, the LAB\/LF supplement was prepared from 10 viable probiotics expressing LF, and the inactivated LAB\/LF supplement was prepared from 10 inactivated probiotics expressing LF. A model of obese\/NAFLD mice induced by a high-fat diet was established, and the mice were randomly divided into four groups and fed with a placebo, LAB, LAB\/LF, or inactivated LAB daily for four weeks via oral gavage. The body weight, food intake, organ weight, biochemistry, and hepatic histopathological alterations and severity scoring were measured. The results revealed that the obese mice fed with any one of the three probiotic mixtures prepared from recombinant probiotics for four weeks exhibited considerably improved hepatic steatosis. These findings confirmed the assumption that specific probiotic strains or LF supplements could help to control NAFLD, as suggested in previous reports. Our data also suggest that the probiotics and LFs in probiotic mixtures contribute differently to improving the efficacy against NAFLD, and the expressed LF content in probiotics may help to boost their efficacy in comparison with the original probiotic mixtures. Moreover, when these LF-expressing probiotics were further inactivated by sonication, they displayed better efficacies than the viable probiotics against NAFLD. This study has provided intriguing data supporting the potential of recombinant probiotics in improving hepatic steatosis.<\/jats:p>","DOI":"10.3390\/microorganisms10112215","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T02:03:58Z","timestamp":1668045838000},"page":"2215","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Oral Administration of Recombinant Lactoferrin-Expressing Probiotics Ameliorates Diet-Induced Lipid Accumulation and Inflammation in Non-Alcoholic Fatty Liver Disease in Mice"],"prefix":"10.3390","volume":"10","author":[{"given":"Zhen-Shu","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Safety, Health and Environmental Engineering, Ming Chi University of Technology, New Taipei City 24301, Taiwan"},{"name":"Chronic Diseases and Health Promotion Research Center, Chang Gung University of Science and Technology, Chiayi 61363, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Lin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, National Chung Hsing University, Taichung 40249, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-We","family":"Ku","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, National Chung Hsing University, Taichung 40249, Taiwan"},{"name":"Animal and Plant Disease Control Center Yilan County, Wujie Township, Yilan County 268015, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1230-1532","authenticated-orcid":false,"given":"Po-Wen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, National Chung Hsing University, Taichung 40249, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"key":"ref_1","first-page":"434","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin. Proc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3748\/wjg.v20.i7.1712","article-title":"Clinical approaches to non-alcoholic fatty liver disease","volume":"20","author":"Schwenger","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrgastro.2013.34","article-title":"NAFLD in Asia\u2014As common and important as in the West","volume":"10","author":"Farrell","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2006.06.013","article-title":"Hepatic histology in obese patients undergoing bariatric surgery","volume":"45","author":"Machado","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis","volume":"24","author":"Leoni","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"15518","DOI":"10.3748\/wjg.v20.i42.15518","article-title":"Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease","volume":"20","author":"Paolella","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1484598","DOI":"10.1155\/2019\/1484598","article-title":"Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease","volume":"2019","author":"Xiao","year":"2019","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/apt.15416","article-title":"Review article: Can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease","volume":"50","author":"Koopman","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tifs.2016.09.011","article-title":"Paraprobiotics: Evidences on their ability to modify biological responses, inactivation methods and perspectives on their application in foods","volume":"58","author":"Almada","year":"2016","journal-title":"Trends Food Sci. Technol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tifs.2018.03.009","article-title":"Postbiotics: An evolving term within the functional foods field","volume":"75","author":"Garcia","year":"2018","journal-title":"Trends Food Sci. Technol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.fsi.2018.11.017","article-title":"Multiple-strain probiotics appear to be more effective in improving the growth performance and health status of white shrimp, Litopenaeus vannamei, than single probiotic strains","volume":"84","author":"Wang","year":"2018","journal-title":"Fish Shellfish Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.2174\/138161209788453202","article-title":"Lactoferrin as a natural immune modulator","volume":"15","author":"Actor","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/lam.13398","article-title":"Anti-adipogenesis and metabolism-regulating effects of heat-inactivated Streptococcus thermophilus MN-ZLW-002","volume":"72","author":"Kang","year":"2021","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_17","first-page":"2641","article-title":"Daily intake of heat-killed Lactobacillus plantarum L-137 improves inflammation and lipid metabolism in overweight healthy adults: A randomized-controlled trial","volume":"59","author":"Tanaka","year":"2019","journal-title":"Randomized Control. Trial"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"111066","DOI":"10.1016\/j.foodres.2022.111066","article-title":"Lactiplantibacillus plantarum K8-based paraprobiotics prevents obesity and obesity-induced inflammatory responses in high fat diet-fed mice","volume":"155","author":"Lim","year":"2022","journal-title":"Food Res. Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12934-020-01426-w","article-title":"Postbiotics-parabiotics: The new horizons in microbial biotherapy and functional foods","volume":"19","author":"Nataraj","year":"2020","journal-title":"Microb. Cell Factories"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10534-014-9740-9","article-title":"Lactoferrin differently modulates the inflammatory response in epithelial models mimicking human inflammatory and infectious diseases","volume":"27","author":"Frioni","year":"2014","journal-title":"BioMetals"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jpeds.2016.02.071","article-title":"Overview of Lactoferrin as a Natural Immune Modulator","volume":"173","author":"Legrand","year":"2016","journal-title":"J. Pediatr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1007\/s00018-005-5372-0","article-title":"Lactoferrin: An important host defence against microbial and viral attack","volume":"62","author":"Valenti","year":"2005","journal-title":"Cell Mol. Life Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/ars.2015.6458","article-title":"Lactoferrin, a Pleiotropic Protein in Health and Disease","volume":"24","author":"Mayeur","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1080\/10408398.2014.995264","article-title":"A role for whey-derived lactoferrin and immunoglobulins in the attenuation of obesity-related inflammation and disease","volume":"57","author":"Brimelow","year":"2015","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"937","DOI":"10.5604\/17322693.1021110","article-title":"A remedy against obesity? The role of lactoferrin in the metabolism of glucose and lipids","volume":"66","author":"Artym","year":"2012","journal-title":"Postepy Hig. Med. Dosw."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jff.2016.01.022","article-title":"Bovine lactoferrin suppresses high-fat diet induced obesity and modulates gut microbiota in C57BL\/6J mice","volume":"22","author":"Sun","year":"2016","journal-title":"J. Funct. Foods"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Li, Y.-C., and Hsieh, C.-C. (2014). Lactoferrin dampens high-fructose corn syrup-induced hepatic manifestations of the metabolic syndrome in a murine model. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0097341"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1017\/S0007114508199445","article-title":"Effects of high-calcium diets with different whey proteins on weight loss and weight regain in high-fat-fed C57BL\/6J mice","volume":"102","author":"Pilvi","year":"2009","journal-title":"Br. J. Nutr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jff.2011.08.001","article-title":"Metabolic effects of lactoferrin during energy restriction and weight regain in diet-induced obese mice","volume":"4","author":"Shi","year":"2012","journal-title":"J. Funct. Foods"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1079\/BJN20041090","article-title":"Bovine lactoferrin reduces plasma triacylglycerol and NEFA accompanied by decreased hepatic cholesterol and triacylglycerol contents in rodents","volume":"91","author":"Takeuchi","year":"2004","journal-title":"Br. J. Nutr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12986-015-0049-7","article-title":"Compared to casein, bovine lactoferrin reduces plasma leptin and corticosterone and affects hypothalamic gene expression without altering weight gain or fat mass in high fat diet fed C57\/BL6J mice","volume":"12","author":"McManus","year":"2015","journal-title":"Nutr. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Liu, Z.-S., Lin, C.-F., Lee, C.-P., Hsieh, M.-C., Lu, H.-F., Chen, Y.-F., Ku, Y.-W., and Chen, P.-W. (2021). A Single Plasmid of Nisin-Controlled Bovine and Human Lactoferrin Expressing Elevated Antibacterial Activity of Lactoferrin-Resistant Probiotic Strains. Antibiotics, 10.","DOI":"10.3390\/antibiotics10020120"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-010-0166-z","article-title":"Health benefits of probiotics: Are mixtures more effective than single strains?","volume":"50","author":"Chapman","year":"2011","journal-title":"Eur. J. Nutr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/00439339.2021.1883412","article-title":"Probiotics as therapeutic, antioxidant and immunomodulatory agents against poultry coccidiosis","volume":"77","author":"Mohsin","year":"2021","journal-title":"World\u2019s Poult. Sci. J."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Gu, Q., Yin, Y., Yan, X., Liu, X., Liu, F., and McClements, D.J. (2022). Encapsulation of multiple probiotics, synbiotics, or nutrabiotics for improved health effects: A review. Adv. Colloid Interface Sci., 102781.","DOI":"10.1016\/j.cis.2022.102781"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1099\/ijsem.0.004107","article-title":"A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae","volume":"70","author":"Zheng","year":"2020","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Oligschlaeger, Y., and Shiri-Sverdlov, R. (2020). NAFLD Preclinical Models: More than a Handful, Less of a Concern?. Biomedicines, 8.","DOI":"10.3390\/biomedicines8020028"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12072-017-9838-6","article-title":"Translating scientific discovery: The need for preclinical models of nonalcoholic steatohepatitis","volume":"12","author":"Oseini","year":"2018","journal-title":"Hepatol. Int."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Recena Aydos, L., Aparecida do Amaral, L., Serafim de Souza, R., Jacobowski, A.C., Freitas Dos Santos, E., and Rodrigues Macedo, M.L. (2019). Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in C57bL\/6 Models. Nutrients, 11.","DOI":"10.3390\/nu11123067"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Van Herck, M.A., Vonghia, L., and Francque, S.M. (2017). Animal Models of Nonalcoholic Fatty Liver Disease\u2014A Starter\u2019s Guide. Nutrients, 9.","DOI":"10.3390\/nu9101072"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5650\/jos.ess17038","article-title":"Dietary Starfish Oil Prevents Hepatic Steatosis and Hyperlipidemia in C57BL\/6N Mice Fed High-fat Diet","volume":"66","author":"Beppu","year":"2017","journal-title":"J. Oleo Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13098-021-00647-2","article-title":"Diet-induced obesity in animal models: Points to consider and influence on metabolic markers","volume":"13","author":"Sediyama","year":"2021","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/jgh.12271","article-title":"Characteristics and diagnosis of NAFLD\/NASH","volume":"28","author":"Hashimoto","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: Distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Piazzolla, V.A., and Mangia, A. (2020). Noninvasive Diagnosis of NAFLD and NASH. Cells, 9.","DOI":"10.3390\/cells9041005"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Mazzaccara, C., Labruna, G., Cito, G., Scarf\u00f2, M., De Felice, M., Pastore, L., and Sacchetti, L. (2008). Age-Related Reference Intervals of the Main Biochemical and Hematological Parameters in C57BL\/6J, 129SV\/EV and C3H\/HeJ Mouse Strains. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003772"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: Disentangling microbial signatures from metabolic disorders","volume":"17","author":"Vigliotti","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"979515","DOI":"10.1155\/2015\/979515","article-title":"Gut Microbiota: Association with NAFLD and Metabolic Disturbances","volume":"2015","author":"Lau","year":"2015","journal-title":"BioMed. Res. Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4254\/wjh.v7.i3.559","article-title":"Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease","volume":"7","author":"Ferolla","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Meroni, M., Longo, M., and Dongiovanni, P. (2019). The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies. Nutrients, 11.","DOI":"10.3390\/nu11112642"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/hep.20023","article-title":"Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver","volume":"39","author":"Bugianesi","year":"2004","journal-title":"Hepatology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(13)70174-8","article-title":"Effects of iron overload on chronic metabolic diseases","volume":"2","author":"Manco","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/hep.24038","article-title":"Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease","volume":"53","author":"Nelson","year":"2011","journal-title":"Hepatology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1053\/j.gastro.2009.11.013","article-title":"HFE Genotype, Parenchymal Iron Accumulation, and Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease","volume":"138","author":"Valenti","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"7183","DOI":"10.1039\/D0FO00910E","article-title":"Recombinant human lactoferrin attenuates the progression of hepatosteatosis and hepatocellular death by regulating iron and lipid homeostasis in ob\/ob mice","volume":"11","author":"Guo","year":"2020","journal-title":"Food Funct."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00394-018-1790-2","article-title":"Adipose tissue inflammation and metabolic syndrome. The proactive role of probiotics","volume":"58","author":"Torres","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Siciliano, R., Reale, A., Mazzeo, M., Morandi, S., Silvetti, T., and Brasca, M. (2021). Paraprobiotics: A New Perspective for Functional Foods and Nutraceuticals. Nutrients, 13.","DOI":"10.3390\/nu13041225"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/10\/11\/2215\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:13:19Z","timestamp":1760145199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/10\/11\/2215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":60,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["microorganisms10112215"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms10112215","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]}}}